Stoneridge Investment Partners LLC Acquires New Holdings in Corteva, Inc. $CTVA

Stoneridge Investment Partners LLC acquired a new stake in Corteva, Inc. (NYSE:CTVA) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 6,828 shares of the company’s stock, valued at approximately $537,000.

Other institutional investors have also recently added to or reduced their stakes in the company. JPL Wealth Management LLC bought a new position in shares of Corteva during the third quarter valued at $25,000. Garton & Associates Financial Advisors LLC bought a new stake in shares of Corteva in the fourth quarter worth $27,000. Bank of Jackson Hole Trust acquired a new stake in Corteva in the fourth quarter valued at $28,000. Cornerstone Financial Management LLC acquired a new stake in Corteva in the fourth quarter valued at $29,000. Finally, Elevation Wealth Partners LLC raised its position in Corteva by 334.6% during the 2nd quarter. Elevation Wealth Partners LLC now owns 339 shares of the company’s stock worth $29,000 after purchasing an additional 261 shares during the last quarter. 81.54% of the stock is owned by institutional investors.

Corteva Stock Up 1.1%

Shares of Corteva stock opened at $76.65 on Friday. The stock’s 50-day moving average is $81.79 and its 200 day moving average is $80.02. Corteva, Inc. has a one year low of $60.53 and a one year high of $90.97. The firm has a market cap of $51.14 billion, a price-to-earnings ratio of 50.76, a PEG ratio of 2.35 and a beta of 0.57. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10.

Corteva (NYSE:CTVA) last issued its earnings results on Thursday, July 30th. The company reported $2.30 earnings per share for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The business had revenue of $6.38 billion during the quarter, compared to the consensus estimate of $6.60 billion. During the same period in the previous year, the company posted $2.20 earnings per share. The firm’s revenue for the quarter was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Equities research analysts anticipate that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be paid a $0.18 dividend. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva’s payout ratio is currently 47.68%.

Analyst Ratings Changes

Several research analysts have commented on CTVA shares. Zacks Research downgraded Corteva from a “strong-buy” rating to a “hold” rating in a report on Tuesday, August 11th. Morgan Stanley raised their price objective on Corteva from $84.00 to $95.00 and gave the stock an “overweight” rating in a research report on Thursday, May 28th. Barclays lifted their price objective on Corteva from $84.00 to $91.00 and gave the stock an “overweight” rating in a research note on Thursday, June 11th. Royal Bank Of Canada upped their target price on Corteva from $97.00 to $103.00 and gave the company an “outperform” rating in a report on Tuesday, July 21st. Finally, Citigroup increased their target price on shares of Corteva from $85.00 to $86.00 and gave the company a “neutral” rating in a research report on Monday, August 3rd. Fourteen equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $91.70.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.